International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection

Nenhuma Miniatura disponível
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Autores
LANTINGA, Marten A.
DARDING, Alexander J. M.
SEVAUX, Ruud G. L. de
ALAM, Ahsan
BLEEKER-ROVERS, Chantal P.
BOBOT, Mickael
GALL, Emilie Cornec-Le
GEVERS, Tom J. G.
HASSOUN, Ziad
MEIJER, Esther
Citação
NEPHRON, v.134, n.4, p.205-214, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Cyst infection is one of the complications of autosomal dominant polycystic kidney disease and polycystic liver disease. The diagnosis is typically made on a mix of clinical, laboratory and imaging abnormalities but the importance of individual items is uncertain. We aimed to perform a Delphi survey amongst physicians to achieve consensus on diagnostic criteria. Methods: We retrieved diagnostic items from the literature and conducted physician and patient interviews. All items were combined to create the online questionnaire. Participants rated each item during 3 consecutive rounds. Items were rated for diagnostic helpfulness for hepatic and renal cyst infection on a 9-point scale with anchors, from extremely unimportant (n = 1) to extremely important (n = 9). We determined consensus with the disagreement index. The median rating of each item was calculated and categorized into inappropriate (<= 3.4), uncertain (3.5-6.4) or appropriate (>= 6.5). By combining all items that reached an appropriate consensus rating, we developed a diagnostic algorithm based on expert consensus. Results: We invited 58 physicians to participate in the survey. In total, 35 (60%) responded to round 1 of which 91% (n = 32) and 86% (n = 30) responded to round 2 and 3, respectively. The final panel included 23 nephrologists, 5 hepatologists, a nuclear medicine specialist and an infectious disease physician from 11 countries (male 67%, mean age 47 +/- 11 years, median clinical experience 21 years). The panel rated the diagnostic helpfulness of 59 potential items. Ultimately, 22 hepatic and 26 renal items were rated appropriate, including positive blood cultures and fluorodeoxyglucose positron-emission CT imaging. Ultrasonography and absence of intracystic bleeding were amongst those deemed uncertain or inappropriate. Subsequently, by combining items rated appropriate, we developed a clinical tool to diagnose hepatic and renal cyst infection. Conclusions: We identified diagnostic items for hepatic and renal cyst infection and developed an expert-based diagnostic algorithm, which may aid physicians in the diagnostic work-up. A prospective study is necessary to validate this algorithm. (C) 2016 S. Karger AG, Basel
Palavras-chave
Autosomal dominant polycystic kidney disease, Polycystic kidney disease, Diagnosis, Infection
Referências
  1. Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605
  2. Bobot M, 2016, CLIN MICROBIOL INFEC, V22, P71, DOI 10.1016/j.cmi.2015.09.024
  3. Brunelli C, 2014, PAIN, V155, P2707, DOI 10.1016/j.pain.2014.09.038
  4. Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59
  5. Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002
  6. Fitch K., 2001, RAND UCLA APPROPRIAT
  7. Gevers TJG, 2013, NAT REV GASTRO HEPAT, V10, P101, DOI 10.1038/nrgastro.2012.254
  8. Ghannoum M, 2012, CLIN J AM SOC NEPHRO, V7, P1682, DOI 10.2215/CJN.01940212
  9. Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458
  10. Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352
  11. Jouret F, 2011, CLIN J AM SOC NEPHRO, V6, P1644, DOI 10.2215/CJN.06900810
  12. Lantinga MA, 2015, ALIMENT PHARM THER, V41, P253, DOI 10.1111/apt.13047
  13. Lantinga MA, 2015, NEPHROL DIAL TRANSPL, V30, P744, DOI 10.1093/ndt/gfu227
  14. Maverakis E, 2014, J AUTOIMMUN, V48-49, P60, DOI 10.1016/j.jaut.2014.01.020
  15. Piccoli GB, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-48
  16. Prowse RL, 2013, J RHEUMATOL, V40, P498, DOI 10.3899/jrheum.121037
  17. Rahbari-Oskoui F, 2014, CLIN J AM SOC NEPHRO, V9, P406, DOI 10.2215/CJN.08940813
  18. Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309
  19. Sinha IP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000393
  20. Steurer J, 2011, SKELETAL RADIOL, V40, P959, DOI 10.1007/s00256-011-1145-z
  21. Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2
  22. Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1
  23. Trevisol DJ, 2015, J HEPATOL, V62, P988, DOI 10.1016/j.jhep.2014.11.043
  24. Vos FJ, 2011, J NUCL MED, V52, P1673, DOI 10.2967/jnumed.111.089714